Rockville Pike, Oct. 17, 2024 (GLOBE NEWSWIRE) -- A newly published study by Fact.MR, a market research and competitive intelligence provider, mentions that revenue from the demand for infant clinical nutrition is approximated to reach a valuation of US$ 27.
55 billion in 2024. The global market is projected to expand at a CAGR of 6% from 2024 to 2034.Top of FormTop of Form Increasing focus on the value of a nutritious diet throughout infancy is driving the demand for specialized infant nutrition products.
More parents have a greater understanding of the benefits of clinical nutrition for their children's growth and development. Preterm births and rising infant death rates in some areas are driving up the need for baby clinical nutrition, particularly for products designed to sustain underweight and preterm neonates. Click to Request a Sample of this Report for Additional Market Insights https://www.
factmr.com/connectus/sample?flag=S&rep_id=10417 The increased population of working mothers in the United States is mostly responsible for the need for newborn therapeutic nutrition products. Since nursing is not always practical for working parents, there is a greater reliance on infant formulae and other nutritional solutions, particularly those that replace breast milk.
Preterm birth rates are among the highest in the country. Prematurely born newborns sometimes require specialist therapeutic nutrition to maintain their growth, which drives the market for products customized to .